[go: up one dir, main page]

DE60331677D1 - Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper - Google Patents

Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper

Info

Publication number
DE60331677D1
DE60331677D1 DE60331677T DE60331677T DE60331677D1 DE 60331677 D1 DE60331677 D1 DE 60331677D1 DE 60331677 T DE60331677 T DE 60331677T DE 60331677 T DE60331677 T DE 60331677T DE 60331677 D1 DE60331677 D1 DE 60331677D1
Authority
DE
Germany
Prior art keywords
human low
kit
antibodies
study
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60331677T
Other languages
English (en)
Inventor
Shoji Furusako
Kamon Shirakawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE60331677D1 publication Critical patent/DE60331677D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60331677T 2002-11-12 2003-11-12 Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper Expired - Lifetime DE60331677D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002328866 2002-11-12
JP2003330775 2003-09-22
PCT/JP2003/014389 WO2004044005A1 (ja) 2002-11-12 2003-11-12 ヒト低分子量ｃｄ１４測定キットおよび抗体

Publications (1)

Publication Number Publication Date
DE60331677D1 true DE60331677D1 (de) 2010-04-22

Family

ID=32314082

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60331677T Expired - Lifetime DE60331677D1 (de) 2002-11-12 2003-11-12 Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper

Country Status (10)

Country Link
US (2) US7465547B2 (de)
EP (1) EP1571160B1 (de)
JP (1) JP4081489B2 (de)
CN (1) CN100558746C (de)
AT (1) ATE460430T1 (de)
AU (1) AU2003280753A1 (de)
CA (1) CA2506580C (de)
DE (1) DE60331677D1 (de)
ES (1) ES2340266T3 (de)
WO (1) WO2004044005A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004044005A1 (ja) 2002-11-12 2004-05-27 Mochida Pharmaceutical Co., Ltd. ヒト低分子量ｃｄ１４測定キットおよび抗体
US7608684B2 (en) * 2002-11-12 2009-10-27 Mochida Pharmaceuticals Co., Ltd. Soluble CD14 antigen
WO2005108429A1 (ja) 2004-05-11 2005-11-17 Mochida Pharmaceutical Co., Ltd. 新規可溶性ｃｄ１４抗原
KR101025723B1 (ko) * 2008-07-18 2011-04-04 주식회사 인포피아 광도파로를 포함하는 면역 크로마토그래피 분석 센서 및이를 이용한 측정방법
JP6018923B2 (ja) * 2011-01-11 2016-11-02 株式会社Ｌｓｉメディエンス 敗血症の予後の予測方法
US10191038B2 (en) * 2011-03-28 2019-01-29 Lsi Medience Corporation Immunological measuring method and measuring kit for whole blood sample
AU2012256682B2 (en) 2011-05-19 2017-02-02 Mochida Pharmaceutical Co., Ltd. Diagnosis of respiratory tract infectious disease using blood specimens
JP5956435B2 (ja) 2011-05-19 2016-07-27 持田製薬株式会社 尿検体を用いた呼吸器感染症の診断
ES2578160T3 (es) * 2011-08-12 2016-07-21 Lsi Medience Corporation Procedimiento de diagnóstico de infecciones de sitio quirúrgico
JP6445969B2 (ja) * 2013-04-30 2018-12-26 持田製薬株式会社 プレセプシン測定による発熱性好中球減少症の診断
SI3628731T1 (sl) 2014-02-26 2021-08-31 Mochida Pharmaceutical Co., Ltd. Novo protitelo proti presepsinu
CN108026522B (zh) * 2015-08-25 2022-04-19 持田制药株式会社 特异性纯化的抗普莱晒谱星抗体
CA3046489A1 (en) 2016-12-07 2018-06-14 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
JP2018140961A (ja) * 2017-02-28 2018-09-13 持田製薬株式会社 ビオチン化ｆ１１０６−１３−３抗体、その製造方法及びその用途
US20210138213A1 (en) 2017-03-30 2021-05-13 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an immune modulatory agent released using an ingestible device
JP6842168B2 (ja) * 2017-05-12 2021-03-17 国立大学法人東北大学 マイクロ水滴内イムノアッセイ
WO2019246312A1 (en) 2018-06-20 2019-12-26 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an immunomodulator
WO2019246317A1 (en) 2018-06-20 2019-12-26 Progenity, Inc. Treatment of a disease or condition in a tissue originating from the endoderm
US20240252795A1 (en) 2018-11-19 2024-08-01 Biora Therapeutics, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
WO2021097684A1 (zh) * 2019-11-19 2021-05-27 深圳迈瑞生物医疗电子股份有限公司 新的抗可溶性cd14亚型抗体及其应用
WO2021097685A1 (zh) * 2019-11-19 2021-05-27 深圳迈瑞生物医疗电子股份有限公司 混合检测PCT和Presepsin的试剂盒、方法以及应用
CN115666704B (zh) 2019-12-13 2025-09-26 比特比德科有限责任公司 用于将治疗剂递送至胃肠道的可摄取装置
CN116500258A (zh) * 2022-01-18 2023-07-28 广州达安基因股份有限公司 基于夹心法荧光免疫层析定量检测cd14的试剂盒及其应用
EP4508434A1 (de) 2022-04-11 2025-02-19 bioMérieux Ptx3-biomarker zur verringerung der antibiotikabehandlung bei neugeborenen
CN114839253B (zh) * 2022-04-21 2024-10-01 深圳市第二人民医院(深圳市转化医学研究院) 血清或血浆中低分子量蛋白定量分析方法及应用
CN116444673B (zh) * 2023-06-14 2023-09-15 北京汇智和源生物技术有限公司 人源膜cd14单克隆抗体及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931385A (en) * 1985-06-24 1990-06-05 Hygeia Sciences, Incorporated Enzyme immunoassays and immunologic reagents
DD286876A5 (de) 1989-08-10 1991-02-07 Ernst-Moritz-Arndt-Universitaet Greifswald,De Verfahren zur bestimmung eines loeslichen humanen monozytenoberflaechenantigens
US5766593A (en) * 1994-12-30 1998-06-16 Amgen Inc. Anti-inflammatory CD14 peptides
WO2000037025A2 (en) * 1998-12-21 2000-06-29 Ludwig Institute For Cancer Research Antibodies to truncated vegf-d and uses thereof
US7326568B2 (en) * 1999-02-04 2008-02-05 University Of Georgia Research Foundation, Inc. Recombinant expression of heterologous nucleic acids in protozoa
US6916628B1 (en) * 1999-09-17 2005-07-12 Mochida Pharmaceutical Co., Ltd. Method for the measurement of soluble CD14 proteins separately
WO2001072993A1 (en) 2000-03-31 2001-10-04 Mochida Pharmaceutical Co., Ltd. Tlr/cd14 binding inhibitor
JPWO2002042333A1 (ja) 2000-11-22 2004-03-25 持田製薬株式会社 Ｃｄ１４／ｔｌｒ結合阻害作用を有する抗ｃｄ１４モノクローナル抗体
WO2004044005A1 (ja) 2002-11-12 2004-05-27 Mochida Pharmaceutical Co., Ltd. ヒト低分子量ｃｄ１４測定キットおよび抗体

Also Published As

Publication number Publication date
CN100558746C (zh) 2009-11-11
US7901900B2 (en) 2011-03-08
ES2340266T3 (es) 2010-06-01
EP1571160B1 (de) 2010-03-10
ATE460430T1 (de) 2010-03-15
EP1571160A1 (de) 2005-09-07
JPWO2004044005A1 (ja) 2006-05-11
CA2506580A1 (en) 2004-05-27
EP1571160A4 (de) 2007-03-21
CA2506580C (en) 2010-08-17
CN1711283A (zh) 2005-12-21
US20070106067A1 (en) 2007-05-10
JP4081489B2 (ja) 2008-04-23
US20090029396A1 (en) 2009-01-29
WO2004044005A1 (ja) 2004-05-27
US7465547B2 (en) 2008-12-16
AU2003280753A1 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
DE60331677D1 (de) Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
ATE517922T1 (de) Stabilisierte einzel-domänen-antikörper in einer pharmazeutischen zusammensetzung ausgestaltet für inhalation
EP2147928A3 (de) Auf Peptiden basierte Immunisierungstherapie zur Behandlung von Atherosklerose und Entwicklung von Peptid-basierten Assays zur Bestimmung von Immunreaktionen gegen oxidiertes Lipoprotein geringer Dichte
RU2009143671A (ru) Высокочувствительные иммуноанализы и наборы для определения представляющих интерес пептидов и белков
EP2343318A3 (de) Antikörper die an ein C-terminales Fragment des Apolipoproteins E binden
ATE414106T1 (de) Pegylierte single-domain-antikörper (dab)
EP2295465A3 (de) Menschliche monoklonale Antikörper gegen das Influenza M2 Protein sowie Methoden zu deren Herstellung und Verwendung
WO2004046194A3 (en) Polyclonal-monoclonal elisa assay for detecting n-terminus probnp
DK1351707T3 (da) Fremgangsmåder til behandling af autoimmunsygdomme hos et individ og in vitro-diagnostiske analyser
NO901899D0 (no) Hiv-peptider, syntetiske hiv-antigener og immunoanalysekit
ATE335763T1 (de) Sandwich-immunoassay zur bestimmung von proanp- teilpeptiden
DE502004000540D1 (de) Verfahren zur Bestimmung der Bildung von Endothelinen zu Zwecken der medizinischen Diagnostik, sowie Antikörper und Kits für die Durchführung eines solchen Verfahrens
WO2001061305A3 (en) Immunoassays detecting or making use of at least two rubber latexallergens
DE60129239D1 (de) Kit und verfahren zur bestimmung von protein esm-1
CA2524002A1 (en) Sars-related proteins
ATE360034T1 (de) Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
WO2018232278A3 (en) PHOSPHO-RAB ANTIBODIES, ASSAYS AND METHODS OF USE
WO2004003155A3 (en) Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors
ES2584982T3 (es) Procedimiento para el diagnóstico de infecciones de bacterias Propionibacterium
WO2006005583A3 (en) Secreted polypeptide species involved in multiple sclerosis
EP1780215A4 (de) Morbus-crohn-antikörperepitoppeptid und reagens zum testen auf morbus crohn
WO2004065936A3 (en) Immunoglobulin e detection in mammalian species
CA2488127A1 (en) Antibodies directed against prothrombin fragment f1+2, the preparation and use thereof
WO2002046769A3 (en) A monoclonal antibody-based diagnostic assay for gamma fibrinogen
JP2004108986A5 (de)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition